STOCKHOLDERS’ EQUITY - Number of Warrants Outstanding, the Weighted Average Exercise Price, and the Aggregate Intrinsic Value (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2026	Dec. 31, 2025
Weighted Average Remaining Contractual Life in Years and Aggregate Intrinsic Value
Weighted Average Exercise Price (in dollars per share)	$ 0.91	$ 1.40
Aggregate Intrinsic Value (in thousands)	$ 79,139	$ 15,489
March 2026 Private Placement
Weighted Average Remaining Contractual Life in Years and Aggregate Intrinsic Value
Weighted Average Exercise Price (in dollars per share)	$ 0.001
Aggregate Intrinsic Value (in thousands)	$ 28,777
Series A and B Warrants
Series A and Series B Warrants
Class of warrant outstanding, beginning balance (in shares)	67,342,325
Series A Warrants exercised into common stock (in shares)	(33,597,860)
Series A Warrants exercised into Pre-Funded Warrants (in shares)	(4,883,465)
Class of warrant outstanding, ending balance (in shares)	28,861,000
Pre-Funded Warrants
Series A and Series B Warrants
Series A Warrants exercised into Pre-Funded Warrants (in shares)	(4,883,465)
Class of warrant outstanding, ending balance (in shares)	15,585,175
Weighted Average Remaining Contractual Life in Years and Aggregate Intrinsic Value
Weighted Average Exercise Price (in dollars per share)	$ 0.001
Aggregate Intrinsic Value (in thousands)	$ 13,132
Pre-Funded Warrants \| March 2026 Private Placement
Series A and Series B Warrants
Pre-Funded Warrants purchased in 2026 Private Placement (in shares)	10,701,710